BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 14655679)

  • 1. Therapy for HDV!
    Taylor JM
    Hepatology; 2003 Dec; 38(6):1581-2. PubMed ID: 14655679
    [No Abstract]   [Full Text] [Related]  

  • 2. Novel targets of anti-hepatitis delta virus therapy.
    Glenn JS; White JM
    Prog Clin Biol Res; 1993; 382():53-60. PubMed ID: 8502717
    [No Abstract]   [Full Text] [Related]  

  • 3. Prenylation of HDAg and antiviral drug development.
    Glenn JS
    Curr Top Microbiol Immunol; 2006; 307():133-49. PubMed ID: 16903224
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of a prenylation inhibitor as a novel antiviral agent.
    Glenn JS; Marsters JC; Greenberg HB
    J Virol; 1998 Nov; 72(11):9303-6. PubMed ID: 9765479
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo antiviral efficacy of prenylation inhibitors against hepatitis delta virus.
    Bordier BB; Ohkanda J; Liu P; Lee SY; Salazar FH; Marion PL; Ohashi K; Meuse L; Kay MA; Casey JL; Sebti SM; Hamilton AD; Glenn JS
    J Clin Invest; 2003 Aug; 112(3):407-14. PubMed ID: 12897208
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Denying the wolf access to sheep's clothing.
    Heller T; Hoofnagle JH
    J Clin Invest; 2003 Aug; 112(3):319-21. PubMed ID: 12897197
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prenylation inhibitors: a novel class of antiviral agents.
    Einav S; Glenn JS
    J Antimicrob Chemother; 2003 Dec; 52(6):883-6. PubMed ID: 14613953
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of hepatitis delta: Need for novel therapeutic options.
    Abbas Z; Abbas M
    World J Gastroenterol; 2015 Aug; 21(32):9461-5. PubMed ID: 26327754
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A prenylation inhibitor prevents production of infectious hepatitis delta virus particles.
    Bordier BB; Marion PL; Ohashi K; Kay MA; Greenberg HB; Casey JL; Glenn JS
    J Virol; 2002 Oct; 76(20):10465-72. PubMed ID: 12239323
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatitis D.
    Husa P; Linhartová A; Nemecek V; Husová L
    Acta Virol; 2005; 49(4):219-25. PubMed ID: 16402678
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatitis D - how is the fight against this foe going?
    Loglio A; Segato S; Lampertico P
    Expert Rev Clin Pharmacol; 2019 Mar; 12(3):169-171. PubMed ID: 30698044
    [No Abstract]   [Full Text] [Related]  

  • 12. Combination of Novel Therapies for HDV.
    Elazar M; Glenn JS
    Viruses; 2022 Jan; 14(2):. PubMed ID: 35215860
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of hepatitis D virus infection on the long-term outcomes of patients with hepatitis B virus and HIV coinfection in the era of highly active antiretroviral therapy: a matched cohort study.
    Sheng WH; Hung CC; Kao JH; Chang SY; Chen MY; Hsieh SM; Chen PJ; Chang SC
    Clin Infect Dis; 2007 Apr; 44(7):988-95. PubMed ID: 17342655
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantification of hepatitis delta virus RNA in serum by consensus real-time PCR indicates different patterns of virological response to interferon therapy in chronically infected patients.
    Le Gal F; Gordien E; Affolabi D; Hanslik T; Alloui C; Dény P; Gault E
    J Clin Microbiol; 2005 May; 43(5):2363-9. PubMed ID: 15872267
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis delta virus.
    Taylor JM
    Virology; 2006 Jan; 344(1):71-6. PubMed ID: 16364738
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Emerging concepts for the treatment of hepatitis delta.
    Elazar M; Glenn JS
    Curr Opin Virol; 2017 Jun; 24():55-59. PubMed ID: 28475945
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reply to: "Increase in HDV replication during steroid therapy - potential implications for testing and treatment strategies".
    Ricco G; Brunetto MR
    J Hepatol; 2024 Jul; 81(1):e51-e53. PubMed ID: 38582305
    [No Abstract]   [Full Text] [Related]  

  • 18. Increase in HDV replication during steroid therapy - potential implications for testing and treatment strategies.
    Patmore LA; van der Eijk AA; Janssen HLA; de Man RA; Sonneveld MJ
    J Hepatol; 2024 Jul; 81(1):e49-e50. PubMed ID: 38036005
    [No Abstract]   [Full Text] [Related]  

  • 19. Does treatment of hepatitis B virus (HBV) infection reduce hepatitis delta virus (HDV) replication in HIV-HBV-HDV-coinfected patients?
    Sheldon J; Ramos B; Toro C; Ríos P; Martínez-Alarcón J; Bottecchia M; Romero M; Garcia-Samaniego J; Soriano V
    Antivir Ther; 2008; 13(1):97-102. PubMed ID: 18389903
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Large hepatitis delta antigen modulates transforming growth factor-beta signaling cascades: implication of hepatitis delta virus-induced liver fibrosis.
    Choi SH; Jeong SH; Hwang SB
    Gastroenterology; 2007 Jan; 132(1):343-57. PubMed ID: 17241884
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.